COLUMBIA, Md., Feb. 1 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it is presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference in New York. The conference is being held February 7-9, 2006 at the Grand Hyatt Hotel. Steve Dubin, President and Peter L. Buzy, CFO, will be presenting on Thursday, February 9 at 3:20 p.m. Eastern Time.
A live audio webcast of Martek’s presentation will be available by accessing the following link: http://www.wsw.com/webcast/ml53/matk
Martek Biosciences Corporation develops manufactures and sells naturally produced products from microalgae and fungi. The Company’s products include: (1) specialty, nutritional oils for infant formula that aid in the development of the eyes and central nervous system in newborns; (2) nutritional supplements and food ingredients that may play a beneficial role in promoting mental and cardiovascular health throughout life; and (3) powerful fluorescent markers for diagnostics, rapid miniaturized screening, and gene and protein detection.
Contact: Kyle Stults Investor Relations (410) 740-0081
Martek Biosciences Corporation
CONTACT: Kyle Stults, Investor Relations of Martek BiosciencesCorporation, +1-410-740-0081
Web site: http://www.martekbio.com/
